Chelsea E. Powell

502 total citations
8 papers, 400 citations indexed

About

Chelsea E. Powell is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Chelsea E. Powell has authored 8 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 2 papers in Cellular and Molecular Neuroscience and 2 papers in Neurology. Recurrent topics in Chelsea E. Powell's work include Ubiquitin and proteasome pathways (3 papers), Protein Degradation and Inhibitors (3 papers) and Neuroscience and Neuropharmacology Research (2 papers). Chelsea E. Powell is often cited by papers focused on Ubiquitin and proteasome pathways (3 papers), Protein Degradation and Inhibitors (3 papers) and Neuroscience and Neuropharmacology Research (2 papers). Chelsea E. Powell collaborates with scholars based in United States, Hong Kong and China. Chelsea E. Powell's co-authors include Nathanael S. Gray, Eric S. Fischer, Katherine A. Donovan, Radosław P. Nowak, Tinghu Zhang, Magda Bahcall, Li Tan, Pasi A. Jänne, Yang Gao and Rani E. George and has published in prestigious journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters and ACS Chemical Biology.

In The Last Decade

Chelsea E. Powell

8 papers receiving 395 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chelsea E. Powell United States 7 351 157 65 38 18 8 400
Anna Koren Austria 10 473 1.3× 178 1.1× 34 0.5× 39 1.0× 25 1.4× 17 583
Kaoru Mitsuhashi Japan 4 314 0.9× 93 0.6× 36 0.6× 49 1.3× 27 1.5× 7 389
Shenxin Zeng China 13 429 1.2× 215 1.4× 138 2.1× 88 2.3× 20 1.1× 33 556
Andrew Conroy United States 5 165 0.5× 124 0.8× 46 0.7× 60 1.6× 31 1.7× 12 255
Ziqin Yan China 10 210 0.6× 85 0.5× 43 0.7× 88 2.3× 20 1.1× 22 307
Julia M. Wagner Germany 6 413 1.2× 154 1.0× 22 0.3× 69 1.8× 17 0.9× 7 523
Elizabeth Remily-Wood United States 10 260 0.7× 69 0.4× 49 0.8× 14 0.4× 32 1.8× 11 364
Mairead Young United States 8 239 0.7× 86 0.5× 79 1.2× 148 3.9× 14 0.8× 8 399
Michelle R. Cronk United States 6 327 0.9× 74 0.5× 88 1.4× 49 1.3× 12 0.7× 7 417

Countries citing papers authored by Chelsea E. Powell

Since Specialization
Citations

This map shows the geographic impact of Chelsea E. Powell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chelsea E. Powell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chelsea E. Powell more than expected).

Fields of papers citing papers by Chelsea E. Powell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chelsea E. Powell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chelsea E. Powell. The network helps show where Chelsea E. Powell may publish in the future.

Co-authorship network of co-authors of Chelsea E. Powell

This figure shows the co-authorship network connecting the top 25 collaborators of Chelsea E. Powell. A scholar is included among the top collaborators of Chelsea E. Powell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chelsea E. Powell. Chelsea E. Powell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Powell, Chelsea E., et al.. (2022). Selective Macrocyclic Inhibitors of DYRK1A/B. ACS Medicinal Chemistry Letters. 13(4). 577–585. 9 indexed citations
2.
Powell, Chelsea E., Guangyan Du, Jonathan W. Bushman, et al.. (2021). Selective degradation-inducing probes for studying cereblon (CRBN) biology. RSC Medicinal Chemistry. 12(8). 1381–1390. 18 indexed citations
3.
Adhikari, Arijit A., Deepti Ramachandran, Snehal N. Chaudhari, et al.. (2021). A Gut-Restricted Lithocholic Acid Analog as an Inhibitor of Gut Bacterial Bile Salt Hydrolases. ACS Chemical Biology. 16(8). 1401–1412. 41 indexed citations
4.
Li, Zhengnian, Chelsea E. Powell, Brian J. Groendyke, et al.. (2020). Discovery of a series of benzopyrimidodiazepinone TNK2 inhibitors via scaffold morphing. Bioorganic & Medicinal Chemistry Letters. 30(19). 127456–127456. 4 indexed citations
5.
Groendyke, Brian J., Chelsea E. Powell, Frédéric Féru, et al.. (2020). Benzopyrimidodiazepinone inhibitors of TNK2. Bioorganic & Medicinal Chemistry Letters. 30(4). 126948–126948. 8 indexed citations
6.
Powell, Chelsea E., Guangyan Du, Jianwei Che, et al.. (2020). Selective Degradation of GSPT1 by Cereblon Modulators Identified via a Focused Combinatorial Library. ACS Chemical Biology. 15(10). 2722–2730. 68 indexed citations
7.
Hatcher, John M., Guowei Wu, Jie Zhu, et al.. (2018). SRPKIN-1: A Covalent SRPK1/2 Inhibitor that Potently Converts VEGF from Pro-angiogenic to Anti-angiogenic Isoform. Cell chemical biology. 25(4). 460–470.e6. 96 indexed citations
8.
Powell, Chelsea E., Yang Gao, Li Tan, et al.. (2018). Chemically Induced Degradation of Anaplastic Lymphoma Kinase (ALK). Journal of Medicinal Chemistry. 61(9). 4249–4255. 156 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026